USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.

Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, Legrave N, Koenis DS, Koifman G, Sugimoto Y, Llorian Sopena M, MacRae J, Nye E, Howell M, Snijders AP, Prachalias A, Zen Y, Sarker D, Behrens A
Nat Commun. 2022 Apr 19;13(1):2070. doi: 10.1038/s41467-022-29684-9. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.